Anavex Life Sciences Corp.
AVXL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001314052
No open-market purchases or sales by Anavex Life Sciences Corp. insiders were filed in the last 90 days; 180 institutions reported holding it in 13F filings for Q2 2026, worth $95.8M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Anavex Life Sciences Corp. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 143 | 153 | +10 |
| Shares | 25.1M | 25.9M | +816.1K (+3.3%) |
| Value | $164.1M | $240.8M | +$76.7M (+46.7%) |
New holders (27)
Institutions that held Anavex Life Sciences Corp. at the end of Q4 2023 but not at the end of Q3 2023.
Sold out (17)
Institutions that held Anavex Life Sciences Corp. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Marshall Wace, LLP | 156,078 | $1.02M |
| Occudo Quantitative Strategies LP | 60,288 | $394.9K |
| Hennion & Walsh Asset Management, Inc. | 59,550 | $390.1K |
| Raymond James Financial Services Advisors, Inc. | 31,155 | $204.1K |
| Schonfeld Strategic Advisors LLC | 26,287 | $172.2K |
| Bridgefront Capital, LLC | 21,047 | $137.9K |
| Dynamic Technology Lab Private Ltd | 20,588 | $135.0K |
| Two Sigma Advisers, LP | 14,200 | $93.0K |
| Saturna Capital CORP | 12,540 | $82.1K |
| Qube Research & Technologies Ltd | 11,796 | $77.3K |
| Dark Forest Capital Management LP | 11,530 | $75.5K |
| ExodusPoint Capital Management, LP | 10,131 | $66.0K |
| Clear Street Markets LLC | 3,150 | $21.0K |
| Allspring Global Investments Holdings, LLC | 3,061 | $20.0K |
| Northwestern Mutual Wealth Management Co | 1,335 | $8.74K |
| Flaharty Asset Management, LLC | 1,000 | $6.55K |
| Huntington National Bank | 700 | $4.58K |